Monday, May 25, 2026

< + > Trends in Healthcare Marketing and Patient Experience – Healthcare IT Today Podcast Episode 193

For the 193rd episode of the Healthcare IT Today Podcast, we are talking about trends in healthcare marketing and patient experience! We kick this episode off by discussing how we think the healthcare website is changing this year. Then, we debate where we think AI is affecting how patients seek and receive care. Next, we share the marketing message that surprised us at the Swaay.Health LIVE conference. Lastly, we conclude this episode by talking about our key takeaways from Swaay.Health LIVE that we think health IT leaders need to know.

Here’s a preview of the topics and questions we discuss in this episode:

  • How is the healthcare website changing in 2026?
  • Where is AI changing how patients seek and get care?
  • What marketing message surprised you at the Swaay.Health LIVE conference?
  • What are the key takeaways from Swaay.Health LIVE that Health IT leaders need to know?

Now, without further ado, we’re excited to share with you the next episode of the Healthcare IT Today podcast.

We publish a new Healthcare IT Today podcast every ~2 weeks. Thanks to our friends at Healthcare Now Radio, you’ll be able to listen to the latest episodes of Healthcare IT Today on their radio station for the first two weeks. Then, we’ll be publishing each episode as a podcast and YouTube video here after it finishes on the radio.

You can also subscribe to the Healthcare IT Today podcast on any of the following platforms:

Thanks for listening to Healthcare IT Today and if you enjoy the content we’re sharing, please rate the podcast on your favorite podcasting platform.

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on HealthcareITToday.com.

If you work in Healthcare IT, we’d love to hear where you agree and/or disagree with the perspectives we shared. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, with @Colin_Hung or @techguy on Twitter, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!

Listen to Our Latest Episodes:



< + > Why HIPAA-Compliant Telehealth Requires a Flexible, Device-Agnostic Workforce

The following is a guest article by David Matalon, Chief Executive Officer at Venn

Telehealth has expanded access to care and fundamentally changed how healthcare organizations deliver services, with projections suggesting telehealth may account for up to 30% of U.S medical visits in 2026. Behind every telehealth appointment is a broad workforce that includes coders, billing specialists, insurance professionals, and contractors – most of whom work remotely, hybrid, or even offshore. This increasingly blended workforce reflects real changes in how care and support services are delivered. As more people rely on telehealth services, there’s a growing demand for professionals enabling virtual care – as well as solutions that ensure data remains secure across these distributed workforces.

However, traditional security model approaches – such as shipping corporate-managed laptops to onboard this distributed workforce, or virtual desktops which rely on remote hosting, are too slow and complex to support the speed and scale needed. This current mismatch is fueling the need for a more flexible, device-agnostic security model that will enforce compliance without restricting how and where work gets done.

Ensuring HIPAA Compliance Across a Distributed Workforce 

With 73% of healthcare leaders expecting half of their workforce to be hybrid in 2026, maintaining HIPAA compliance across diverse devices and environments will be critical for protecting patient data. It’s well known that HIPAA requires organizations to implement safeguards that include strong policies and controls that prevent the unauthorized access, use, or disclosure of electronic protected health information (ePHI). As a default, these responsibilities extend to anyone who accesses this data, including contractors, vendors, offshore workers, and other business associates.

For healthcare organizations, enforcing consistent security policies can be challenging with remote contractors using personal or third-party devices that companies don’t fully control or manage. For an industry severely understaffed, maintaining a high level of control and consistent protection for ePHI is difficult. Without strong access controls and monitoring, the risk of unauthorized access or disclosure increases. 

Legacy security for these scenarios was built around the endpoint. IT leaders would lock down the device, control the hardware, and manage everything installed on it, with the assumption being that protecting the machine protected the data on it. But that model doesn’t hold up when your workforce is spread across geographies, on personal laptops, contractor machines, and home offices.

Ensuring HIPAA compliance in a distributed environment requires a reframe: protecting the work itself. Encrypting and isolating work applications and ePHI directly on the endpoint, regardless of what device is being used to access them.

Enabling Secure, Device-Agnostic Access for Telehealth Workforces

To fully embrace this next phase of telehealth, healthcare organizations need workforce models that are more flexible by design, and the security infrastructure to match. 

Allowing employees and contractors to use their own devices can remove much of that friction. It makes the onboarding process a lot faster and gives organizations more flexibility in how they want to build and scale their workforce. 

But device flexibility only works if compliance travels with it. HIPAA doesn’t change based on who owns the laptop, so the obligation to control access to ePHI applies regardless of whether someone is using a corporate-issued machine or their own. That’s the challenge that a device-agnostic model solves: giving people the freedom to work on any device, while ensuring the organization never loses control of the data.

Building a Secure, Flexible Future for Telehealth Workforces

The practical shift starts at the endpoint. Rather than restricting access by locking down entire devices, IT teams can isolate ePHI and healthcare applications inside a protected workspace directly on the user’s machine, fully separated from personal activity. 

This allows healthcare organizations to onboard remote workers and contractors in minutes instead of days, without shipping laptops or spinning up complex virtual desktops. Offboarding is just as fast, since access can be revoked instantly, with no equipment to retrieve. For an industry dealing with persistent staffing pressure and high contractor turnover, that agility matters.

As telehealth continues to reshape care delivery, the organizations best positioned to scale are those that stop treating device ownership as their security strategy. HIPAA compliance doesn’t require that IT teams control the hardware; it just requires that they keep sensitive data secure, regardless of what device it’s on. A model that isolates and protects ePHI at the endpoint, regardless of what device it sits on, gives healthcare organizations the flexibility to grow their distributed workforce without compromising the trust patients place in them.

About David Matalon

David Matalon is the Founder and CEO at Venn, the leader in flexible workforce enablement. As a 5-time founder, David has experience running companies focused on securing and delivering applications for distributed workforces. He led businesses that worked on virtual desktop (VDI) technologies and security/compliance for remote teams. Venn is the innovator behind Blue Border, a purpose-built technology that creates a secure, IT-controlled work environment on a user’s own PC or Mac—separating work and personal activity without locking down the device or relying on virtual desktops. He earned his undergraduate degree from NYU’s Stern School of Business and holds a master’s degree from Columbia University. You can follow him on LinkedIn here.



< + > Roche Enters Into a Definitive Merger Agreement to Acquire PathAI to Transform AI-Driven Diagnostics

  • PathAI’s Best-In-Class Image Management System (IMS) with Advanced AI Analysis and Workflow Capabilities will Complement Roche’s Digital Pathology Portfolio to Drive Laboratory Efficiency
  • Combining Roche’s Strong Position in Companion Diagnostics and PathAI’s Advanced AI Platform Helps Accelerate Clinical Therapy Development, Foster the Discovery of New Biomarkers, and Create Novel Diagnostic Tools
  • These Integrated Capabilities will Accelerate the Shift from Broad Intervention Toward Personalised Healthcare for Patients

Roche announced today that it has entered into a definitive merger agreement to acquire PathAI, a US-based company in digital pathology and AI-powered technology for pathology laboratories and the biopharma industry. This acquisition builds on the successful partnership between Roche and PathAI, established in 2021 and scaled up in 2024 to include the development of AI-enabled companion diagnostic algorithms. Subject to the closing of the transaction, which is expected in the second half of the year, the acquired entity will become part of the Diagnostics division.

This acquisition strengthens Roche’s position in Digital Pathology, which is transforming extensive manual workflows into fully automated, AI-driven processes and insights. Digital pathology enables the creation of high-resolution digital images from physical tissue on slides, allowing pathologists to use AI tools to facilitate diagnostic workflows and provide patients with faster results.

“Digital pathology has the potential to improve precision diagnosis of cancer and enable physicians to offer better-tailored treatment regimens,” said Matt Sause, CEO at Roche Diagnostics. “Bringing PathAI into Roche Diagnostics will allow us to combine their best-in-class digital pathology tools with our leading oncology diagnosis platforms to deliver better insights for physicians and potentially better outcomes for patients worldwide.”

Andy Beck, Co-Founder and CEO at PathAI, adds, “Joining forces with Roche marks a new era for PathAI, enabling us to realise our mission of improving patient outcomes through AI-powered pathology at unprecedented scale and speed. Roche’s global infrastructure and expertise will bring our digital diagnostics technology to patients worldwide.”

PathAI’s AISight IMS software interface is efficient and user-friendly, seamlessly integrating advanced analysis and workflow capabilities within the digital pathology laboratory. In the rapidly growing pathology market, Roche intends to scale this solution globally.

In addition, the expanded capabilities strengthen Roche’s competitiveness in precision medicine by enhancing its biopharma services. PathAI’s strength in AI-driven solutions, including clinical trial support and translational research, will complement Roche’s deep expertise in companion diagnostics. Combining these capabilities will foster the discovery of new biomarkers, potential drug targets, and novel diagnostic tools, increasing the value Roche can bring to biopharma companies.

About Roche

Roche is a healthcare company uniquely placed to prevent, stop, and cure diseases by uniting leading science and technology across diagnostics, medicines, and digital solutions.

Roche was founded in Basel, Switzerland, in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 150 countries around the world. It is dedicated to tackling healthcare challenges that place the greatest strain on patients, families, communities, and healthcare systems. Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases, and immunology with the aim of providing real and positive change for patients, the people they love, and the professionals who care for them.

Genentech in the United States is a fully owned subsidiary in the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.

For more information, please visit roche.com.

Originally announced May 6th, 2026



Sunday, May 24, 2026

< + > Bonus Features – May 24, 2026 – 74% of compromised healthcare devices store EHR credentials, 62% of orgs say legacy data archiving impacts patient care, plus 31 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT that we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.

Studies

Partnerships

Products

Implementations

Company News

People

If you have news that you’d like us to consider for a future edition of Healthcare IT Today Bonus Features, please submit them on this page. Please include any relevant links and let us know if news is under embargo. Note that submissions received after the close of business on Thursday may not be included in Bonus Features until the following week.



Saturday, May 23, 2026

< + > Weekly Roundup – May 23, 2026

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives you a chance to catch up on anything you may have missed during the week.

Healthcare IT History Doesn’t Repeat, But It Does Rhyme. The industry has a history of implementing best-of-breed clinical solutions, from EHRs to labs to pharmacy management, and having to clean up the mess that point solutions can leave. John Lynn said he sees the same thing happening with AI: Every CIO wants an AI platform, but the market only offers best-of-breed AI at the moment. Will a platform emerge? Read more…

How Physicians Are Using AI to Improve Care and Coding. At the recent Navina Ascend user conference, John sat down with three users that benefit from summaries of patients’ records and meeting Medicare Advantage documentation requirements, among other things. Read more… 

How Evolving Regulatory Requirements and Reimbursement Models Influence Health IT Strategy. We asked the Healthcare IT Today experts what the current environment means for providers and payers. Organizations need to emphasize accountability, collaboration, governance, transparency, and adaptability. Read more…

Interop and Data Standardization Challenges That Hinder Payer-Provider Collaboration. Improving data governance, accuracy, and usability help organizations addresses these concerns, according to the Healthcare IT Today community. It’s worth noting that often starts by breaking down data silos. Read more…

Curing Clinicians’ Recall Anxiety and Scheduling Friction. Colin Hung connected with Kate Steele at Axia Women’s Health, an eClinicalWorks customer that found success with patient-self-scheduling and AI scribing by showing physicians evidence of its benefits. Read more…

Is Being a Disruptor Still a Good Thing? Alan Shoebridge at Providence has published an annual list of healthcare disruptors for several years now. He joined Colin and indicated that policy, labor, and social shifts tend to be more disruptive than technology. Read more…

Leading Healthcare CIOs on LinkedIn. Meet the technology leaders at healthcare organizations sharing insights on AI, digital transformation, and the unique needs of rural and community-based organizationsRead more…

Life Sciences Today Podcast: Sanofi’s Rare Humanitarian Program. Bonnie Anderson at Sanofi talked to Danny Lieberman about the company’s 30-year effort to provide free enzyme replacement therapy in countries where no reimbursement pathway exists. More than 3,600 patients have benefitted to date. Read more…

CIO Podcast: ACOs and Long-Term Care. Mike Camacho at Sound Long Term Care joined John to discuss the role of data, care coordination, and technology in supporting value-based long-term care. Read more…

Why Most Health Systems Can’t Scale AI Past the Pilot. Eric Farr at BrainStorm said traditional app deployment processes don’t work for AI because models and capabilities evolve quickly. Readiness strategies for AI should be continuous, role-specific, easily audited, and tied to user behavior. Read more…

Workforce Readiness Is the Missing Link in Healthcare AI Adoption. Healthcare leaders underestimate the organizational change required to scale AI safely and effectively. Mechanisms that provide visibility, oversight, and concrete guardrails are necessary, noted Anupama Shashank at Kyndryl. Read more…

RCM Moves to the Fore as Margin Pressures Intensify. The front end of the revenue cycle is underinvested relative to how much it affects downstream outcomes, according to Inger Sivanthi at Droidal. Addressing this means reducing the gap between when insights are generated and when action can take place. Read more…

Healthcare AI Needs a Job Description. Dr. Scott R Schell at Cognizant outlined why AI needs to be evaluated like a component healthcare infrastructure and not a clinician, as that will help orgs better understand the role AI should play. Read more…

Pre-Bill Prevention Is Now Non-Negotiable in Coding and Denial Management. Revenue risk is no longer isolated to downstream denials or post-payment reviews, noted Ritesh Ramesh at MDaudit. Leaders need real visibility into risk to proactively prevent denials and strengthen financial footing. Read more…

This Week’s Health IT Jobs for May 20, 2026: Maryland-based consultancy eSimplicity is seeking a CTO for its Health division. Read more…

Bonus Features for May 17, 2026: Just 59% of healthcare orgs track the performance of their AI agents; meanwhile, 60% of nurses lack confidence in their org’s AI oversight. Read more…

Funding and M&A Activity:

Thanks for reading and be sure to check out our latest Healthcare IT Today Weekly Roundups.



Friday, May 22, 2026

< + > IT is Easy – Fun Friday

Happy Friday everyone!  I hope you had an amazing week and are ready for a great weekend.

I’m not sure how funny this edition of Fun Friday is for people.  As a former techguy myself, this graphic below definitely hit home when I saw it: (Note: If the graphic is clipeed, you can see the full one here)

I’m still chewing on that last phrase “The Best IT Work is Invisible!”

It’s the truest statement in the world and yet it’s what makes the job so challenging.  Invisible work doesn’t get rewarded.  However, that’s exactly what you want from your IT department.  It’s even worse with healthcare security.  Ideally, you never know your security person’s name (a little exaggerated, but you get the point).  This is changing as the IT solutions make more of a clinical and financial impact on healthcare organizations.  However, even then you need to capture the data that shows the impact.  Otherwise, it will just be invisible.

What do you think of the graphic above?  Does it illustrate well much of the work IT does?



< + > Thirty Years of Free Therapy: Sanofi’s Rare Humanitarian Program – Life Sciences Today Podcast Episode 62

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Bonnie Anderson, Head of Humanitarian Programs, Rare Diseases at Sanofi. For more than 30 years, Sanofi’s Rare Humanitarian Program has provided free enzyme replacement therapy to patients with lysosomal storage disorders — Gaucher, Fabry, Pompe, ASMD, MPS I and II — in countries where no reimbursement pathway exists. What started in 1991 with a single drug for a single disease has grown to cover six diseases across 100+ countries, with more than 3,600 patients treated and over 1,000 patients active today.

In this conversation we talk about what it actually takes to sustain patient access at this scale: how a physician in a country with no reimbursement initiates a request, how the program builds local diagnostic and treating capacity alongside the drug donation, and what changed in 2023 when Sanofi moved the review and approval workflow off spreadsheets and onto Bonterra’s grants management platform — cutting approval turnaround to under 36 hours. We also talk about what three decades of humanitarian access have taught Sanofi about running programs that outlast portfolio changes, M&A, and generational staff turnover.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

  • For someone who has never heard of the program, paint the picture — who is the patient, what disease do they have, and what would happen to them without this?
  • The program started in 1991 with Genzyme for Gaucher disease. What was the original decision inside Genzyme that created it, and does that still hold today?
  • Walk me through what happens from the moment a treating physician in a country like India or Egypt identifies a patient they think might qualify, through to the first infusion. Where does the physician meet the program?
  • The program is case-by-case, country-by-country. What does “case-by-case” actually mean in practice — what are the criteria, and what kinds of requests don’t get approved?
  • How does the program think about long-term commitment to a patient across decades of pharma portfolio changes and M&A?
  • One of the things that stood out in the Orphanet paper is that the program builds local clinical infrastructure — advisory boards, training, diagnostics — not just drug logistics. Why was that decision made early, and what does it look like in a country today?
  • Thirty years in, what does the program look like? Is it still there? Has it wound down? Has it evolved into something else as local capacity matured?
  • Before 2023, the review and approval workflow ran on email, spreadsheets, and PDFs. What did a bad week look like back then, and what was the moment you knew the manual process couldn’t scale?
  • You moved to Bonterra’s grants management platform in 2023. Approval turnaround is now reportedly under 36 hours. What does that delta mean for a patient and their physician?
  • A grants management platform wasn’t originally built for medical access programs — it’s CSR software. Why was that the right shape for this workflow, versus a purpose-built managed access platform?
  • What do you think about the cyber and privacy architecture of a program that crosses that many borders?
  • What is the biggest anti-pattern in your industry of humanitarian access?

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!



< + > Trends in Healthcare Marketing and Patient Experience – Healthcare IT Today Podcast Episode 193

For the 193rd episode of the Healthcare IT Today Podcast , we are talking about trends in healthcare marketing and patient experience! We ki...